Stage IVB Vaginal Cancer: Clinical Trials

2 trials for Stage IVB Vaginal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Stage IVB Vaginal Cancer: new trials by email Literature Review of Stage IVB Vaginal Cancer trials Research Report on Stage IVB Vaginal Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer
Phase 1CompletedNational Cancer Institute (NCI)242006-03-012013-01-11
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer
Phase 1CompletedNational Cancer Institute (NCI)151999-08-012013-02-28

Narrower conditions

Carcinoma, Ovarian Epithelial (2)  ·  Uterine Cervical Neoplasms (2)  ·  Vaginal Neoplasms (2)  ·  Vulvar Neoplasms (2)  ·  Adenocarcinoma, Follicular (1)  ·  Adrenocortical Carcinoma (1)  ·  Anus Neoplasms (1)  ·  Appendiceal Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Islet Cell (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Adnexal Diseases (2)  ·  Carcinoma (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Ovarian Diseases (2)

Interventions

3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1)  ·  Brachytherapy (1)  ·  Cisplatin (1)  ·  Interleukin-12 (1)  ·  Interleukin-12 Subunit p35 (1)  ·  Therapeutics (1)  ·  Trastuzumab (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

United States (2)

Top investigators

Charles Kunos (1)  ·  William Carson (1)

NIH funding

U01CA062502 (1), U01CA076576 (1)